Biotech Series: Eli Lilly Chief AI Officer Thomas Fuchs on AI's Power to Transform Pharmaceuticals

from Inside the ICE House · host Intercontinental Exchange

AI is revolutionizing pharmaceuticals, moving from a side tool to a core driver of many aspects of the industry. Eli Lilly is leading the way, appointing Thomas Fuchs as its first Chief AI Officer to integrate AI across its pipeline. A NASA and Mount Sinai veteran, Fuchs is turning Lilly’s data into a competitive edge. He joins Inside the ICE House to share how Lilly is building the AI-powered medicine company of the future.

Episode metadata supplied by the publisher feed · Published Sep 4, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Biotech Series: Eli Lilly Chief AI Officer Thomas Fuchs on AI's Power to Transform Pharmaceuticals

0:00 24:30

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Inside the ICE House?

This episode is 24 minutes long.

When was this Inside the ICE House episode published?

This episode was published on September 4, 2025.

Can I download this Inside the ICE House episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!